Drugs / Proflavine Solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02335372 Background | Jun 2013 → Oct 2021 | cervical cancer | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Proflavine Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02335372 ↗ |
| Route | Topical | “Topical application of 0.01% proflavine solution applied for 1 minute to cervix after sites for biopsy have been identified during colposcopy.” NCT02335372 ↗ |